Related Experiment Video

Updated: May 30, 2026

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization
14:55

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Published on: September 1, 2018

An inhibitor of K+ channels modulates human endometrial tumor-initiating cells

Brandon M Schickling1, Nukhet Aykin-Burns, Kimberly K Leslie

  • 1Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. Victoria-korovkina@uiowa.edu.

Cancer Cell International
|August 4, 2011
PubMed
Abstract

Insights

Tetraethylammonium (TEA), a potassium channel blocker, inhibits tumor-initiating cells (TIC) in endometrial cancer. TEA shows potential as an anti-cancer drug targeting TIC to prevent tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Potassium ion (K+) channels are implicated as oncogenes in solid tumor growth.
  • The role of K+ channels in cancer progression, particularly concerning tumor-initiating cells (TIC), remains unclear.

Purpose of the Study:

  • To investigate the role of K+ channels in endometrial cancer progression.
  • To evaluate the effect of K+ channel antagonists on TIC.

Main Methods:

  • Utilized tetraethylammonium (TEA), a non-selective K+ channel antagonist.
  • Assessed the impact of TEA on colony formation and in vitro growth of endometrial cancer cells and isolated TIC subpopulations.

Main Results:

  • TEA suppressed colony formation in endometrial cancer cells by inhibiting putative TIC.
  • TEA withdrawal led to enhanced tumorigenesis.
  • TEA inhibited the growth of isolated TIC-enriched subpopulations in vitro.

Conclusions:

  • K+ channel activity significantly contributes to endometrial tumor progression.
  • K+ channel antagonists, like TEA, are potential therapeutic agents for targeting TIC in endometrial cancer.
  • Targeting TIC with K+ channel antagonists may offer a novel strategy for endometrial cancer therapy.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...